Search

everythinglearnresearchcommunity

for

Search:↓

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Early balding men may have insulin resistance, but lifestyle changes can help.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Melatonin may help treat PCOS symptoms in rats.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Women with PCOS have altered brain structure and reduced cognitive performance.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

High testosterone increases heart disease risk in women with PCOS.

Skin tags in severely obese people may indicate higher blood pressure and diabetes risk.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Wheat straw is valuable for its health benefits and various industrial uses.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.